1.World Health Organization (2014) Antimicrobial Resistance: Global Report on Surveillance. Geneva, Switzerland: World Health Organization.
2.Cosgrove, SE (2006) The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clinical Infectious Diseases 42(Suppl. 2), S82-S89.
3.O'Neill, J (2014) Review on Antimicrobial Resistance: Tackling a Crisis for the Health and Wealth of Nations. London, UK: The Review on Antimicrobial Resistance.
4.de Kraker, MEA, Stewardson, AJ and Harbarth, S (2016) Will 10 million people die a year due to antimicrobial resistance by 2050? PLoS Medicine 13, e1002184.
5.World Bank (2017) Drug-resistant Infections: a Threat to Our Economic Future (Report no. 114679). Washington, DC, USA: World Bank,.
6.Spellberg, B, Bartlett, JG and Glibert, DN (2013) The future of antibiotics and resistance. New England Journal of Medicine 368, 299–302.
8.Silbergeld, EK, Graham, J and Price, LB (2008) Industrial food animal production, antimicrobial resistance and human health. Annual Review of Public Health 29, 151–169.
9.Landers, TF et al. (2012) A review of antibiotic use in food animals: perspective, policy and potential. Public Health Reports 127, 4–22.
10.Allen, HK et al. (2010) Call of the wild: antibiotic resistance genes in natural environments. Nature Reviews Microbiology 8, 251–259.
11.Littman, JR (2014) Antimicrobial Resistance and Distributive Justice (dissertation). University College London, London, UK.
12.Gröhn, YT (2015) Progression to multi-scale models and the application to food system intervention strategies. Preventive Veterinary Medicine 118, 238–246.
13.Armeanu, E, Bonten, MJM and Weinstein, RA (2005) Control of vancomycin-resistant enterococci: one size fits all? Clinical Infectious Diseases 41, 210–216.
14.Bonten, MJM, Austin, DJ and Lipsitch, M (2001) Understanding the spread of antibiotic resistant pathogens in hospitals: mathematical models as tools for control. Clinical Infectious Diseases 33, 1739–1746.
15.Marshall, DA et al. (2015) Applying dynamic simulation modeling methods in healthcare delivery research – the SIMULATE checklist: report of the ISPOR simulation modeling emerging good practices task force. Value in Health 18, 5–16.
16.Grundmann, H and Hellriegel, B (2006) Mathematical modelling: a tool for hospital infection control. Lancet Infectious Diseases 6, 39–45.
17.Lipsitch, M and Samore, MH (2002) Antimicrobial use and resistance: a population perspective. Emerging Infectious Diseases 8, 347–354.
18.Smith, DL, Dushoff, J and Morris, JG Jr (2005) Agricultural antibiotics and human health. PLoS Medicine 2, e232.
19.Temime, L et al. (2008) The rising impact of mathematical modelling in epidemiology: antibiotic resistance research as a case study. Epidemiology and Infection 136, 289–298.
20.Opatowski, L et al. (2013) Contributions of mathematical models to the understanding of the dynamics of nosocomial pathogens in hospitals. Journal des Anti-infectieux 15, 193–203.
21.Doan, TN et al. (2014) Optimizing hospital infection control: the role of mathematical modeling. Infection Control and Hospital Epidemiology 35, 1521–1530.
22.Austin, DJ and Anderson, RM (1999) Studies of antibiotic resistance within the patient, hospitals and the community using simple mathematical models. Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences 354, 721–738.
23.Levin, BR (2001) Minimizing potential resistance: a population dynamics view. Clinical Infectious Diseases 33(Suppl. 3), S161–S169.
24.Levac, D, Colquhoun, H and O'Brien, KK (2010) Scoping studies: advancing the methodology. Implementation Science 5, 69.
25.Arksey, H and O'Malley, L (2005) Scoping studies: towards a methodological framework. International Journal of Social Research Methodology 8, 19–32.
26.Pitman, R et al. (2012) Dynamic transmission modeling: a report of the ISPOR-SMDM modeling good research practices task force-5. Value in Health 15, 828–834.
27.Briggs, AH et al. (2012) Model parameter estimation and uncertainty: a report of the ISPOR-SMDM modeling good research practices task force working group-6. Value in Health 15, 835–842.
28.Eddy, DM et al. (2012) Model transparency and validation: a report of the ISPOR-SMDM modeling good research practices task force-7. Value in Health 15, 843–850.
29.Kijowski, DJ (2014) Responsible Conduct of Research with Computational Models and Simulations (thesis). University of Illinois at Urbana-Champaign, Champaign, IL, USA.
30.Opatowski, L et al. (2011) Contribution of mathematical modeling to the fight against bacterial antibiotic resistance. Current Opinion in Infectious Diseases 24, 279–287.
31.Spicknall, IH et al. (2013) A modeling framework for the evolution and spread of antibiotic resistance: literature review and model categorization. American Journal of Epidemiology 178, 508–520.
32.Arepeva, M et al. (2015) What should be considered if you decide to build your own mathematical model for predicting the development of bacterial resistance? Recommendations based on a systematic review of the literature. Frontiers in Microbiology 6, 352.
33.Abatih, EN et al. (2009) Impact of antimicrobial usage on the transmission dynamics of antimicrobial resistant bacteria among pigs. Journal of Theoretical Biology 256, 561–573.
34.Graesbøll, K et al. (2014) How fitness reduced, antimicrobial resistant bacteria survive and spread: a multiple pig – multiple bacterial strain model. PLoS ONE 9, e100458.
35.Jansen, JP, Kumar, R and Carmeli, Y (2009) Cost-effectiveness evaluation of ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections accounting for antibiotic resistance. Value in Health 12, 234–244.
36.Karlsson, D (2011) Probabilistic network modelling of the impact of penicillin consumption on spread of pneumococci. Epidemiology and Infection 139, 1351–1360.
37.Geli, P et al. (2006) Modeling pneumococcal resistance to penicillin in southern Sweden using artificial neural networks. Microbial Drug Resistance 12, 149–157.
38.Austin, DJ et al. (1999) Vancomycin-resistant enterococci in intensive-care hospital settings: transmission dynamics, persistence, and the impact of infection control programs. Proceedings of the National Academy of Sciences of the United States of America 96, 6908–6913.
39.Beardmore, R and Pena-Miller, R (2010) Rotating antibiotics selects optimally against antibiotic resistance. Mathematical Biosciences and Engineering 7, 527–552.
40.Beardmore, R and Pena-Miller, R (2010) Antibiotic cycling versus mixing: the difficulty of using mathematical models to definitively quantify their relative merits. Mathematical Biosciences and Engineering 7, 923–933.
41.Bergstrom, CT, Lo, M and Lipsitch, M (2004) Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals. Proceedings of the National Academy of Sciences of the United States of America 101, 13285–13290.
42.Bonhoeffer, S, Zur Wiesch, PA and Kouyos, RD (2010) Rotating antibiotics does not minimize selection for resistance. Mathematical Biosciences and Engineering 7, 919–922.
43.Campbell, EM and Chao, L (2014) A population model evaluating the consequences of the evolution of double-resistance and tradeoffs on the benefits of two-drug antibiotic treatments. PLoS ONE 9, e86971.
44.Chamchod, F and Ruan, S (2012) Modeling methicillin-resistant Staphylococcus aureus in hospitals: transmission dynamics, antibiotic usage and its history. Theoretical Biology and Medical Modelling 9, 25.
45.Chow, K et al. (2011) Evaluating the efficacy of antimicrobial cycling programmes and patient isolation on dual resistance in hospitals. Journal of Biological Dynamics 5, 27–43.
46.D'Agata, EMC, Webb, G and Horn, M (2005) A mathematical model quantifying the impact of antibiotic exposure and other interventions on the endemic prevalence of vancomycin-resistant enterococci. Journal of Infectious Diseases 192, 2004–2011.
47.D'Agata, EMC et al. (2007) Modeling antibiotic resistance in hospitals: the impact of minimizing treatment duration. Journal of Theoretical Biology 249, 487–499.
48.D'Agata, EMC et al. (2012) Efficacy of infection control interventions in reducing the spread of multi-drug resistant organisms in the hospital setting. PLoS ONE 7, e30170.
49.Domenech de Cellès, M et al. (2013) Limits of patient isolation measures to control extended-spectrum beta-lactamase-producing Enterobacteriaceae: model-based analysis of clinical data in a pediatric ward. BMC Infectious Diseases 13, 187.
50.Friedman, A, Ziyadi, N and Boushaba, K (2010) A model of drug resistance with infection by health care workers. Mathematical Biosciences and Engineering 7, 779–792.
51.Grima, DT, Webb, GF and D'Agata, EMC (2012) Mathematical model of the impact of a nonantibiotic treatment for Clostridium difficile on the endemic prevalence of vancomycin-resistant enterococci in a hospital setting. Computational and Mathematical Models in Medicine 2012, 605861.
52.Haber, M, Levin, BR and Kramarz, P (2010) Antibiotic control of antibiotic resistance in hospitals: a simulation study. BMC Infectious Diseases 10, 254.
53.Hurford, A et al. (2012) Linking antimicrobial prescribing to antimicrobial resistance in the ICU: before and after an antimicrobial stewardship program. Epidemics 4, 203–210.
54.Joyner, ML, Manning, CC and Canter, BN (2012) Modeling the effects of introducing a new antibiotic in a hospital setting: a case study. Mathematical Biosciences and Engineering 9, 601–625.
55.Kardas-Sloma, L et al. (2011) Impact of antibiotic exposure patterns on selection of community-associated methicillin-resistant Staphylococcus aureus in hospital settings. Antimicrobial Agents and Chemotherapy 55, 4888–4895.
56.Kardas-Sloma, L et al. (2013) Antibiotic reduction campaigns do not necessarily decrease bacterial resistance: the example of methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 57, 4410–4416.
57.Kouyos, RD, zur Wiesch, PA and Bonhoeffer, S (2011) On being the right size: the impact of population size and stochastic effects on the evolution of drug resistance in hospitals and the community. PLoS Pathogens 7, e1001334.
58.Kouyos, RD, zur Wiesch, PA and Bonhoeffer, S (2011) Informed switching strongly decreases the prevalence of antibiotic resistance in hospital wards. PLoS Computational Biology 7, e1001094.
59.Kouyos, R, Klein, E and Grenfell, B (2013) Hospital-community interactions foster coexistence between methicillin-resistant strains of Staphylococcus aureus. PLoS Pathogens 9, e1003134.
60.Laxminarayan, R and Brown, GM (2001) Economics of antibiotic resistance: a theory of optimal use. Journal of Environmental Economics and Management 42, 183–206.
61.Lipsitch, M, Bergstrom, CT and Levin, BR (2000) The epidemiology of antibiotic resistance in hospitals: paradoxes and prescriptions. Proceedings of the National Academy of Sciences of the United States of America 97, 1938–1943.
62.Massad, E, Lundberg, S and Yang, HM (1993) Modeling and simulating the evolution of resistance against antibiotics. International Journal of Bio-Medical Computing 33, 65–81.
63.Massad, E, Burattini, MN and Coutinho, FAB (2008) An optimization model for antibiotic use. Applied Mathematics and Computation 201, 161–167.
64.McBryde, ES and McElwain, DLS (2006) A mathematical model investigating the impact of an environmental reservoir on the prevalence and control of vancomycin-resistant enterococci. Journal of Infectious Diseases 193, 1473–1474.
65.Obolski, U and Hadany, L (2012) Implications of stress-induced genetic variation for minimizing multidrug resistance in bacteria. BMC Medicine 10, 89.
66.Obolski, U, Stein, GY and Hadany, L (2015) Antibiotic restriction might facilitate the emergence of multi-drug resistance. PLoS Computational Biology 11, e1004340.
67.Obolski, U et al. (2016) Antibiotic cross-resistance in the lab and resistance co-occurrence in the clinic: discrepancies and implications in E. coli. Infection, Genetics and Evolution 40, 155–161.
68.Reluga, TC (2005) Simple models of antibiotic cycling. Mathematical Medicine and Biology 22, 187–208.
69.Sébille, V and Valleron, AJ (1997) A computer simulation model for the spread of nosocomial infections caused by multidrug-resistant pathogens. Computers and Biomedical Research 30, 307–322.
70.Sébille, V, Chevret, S and Valleron, A (1997) Modeling the spread of resistant nosocomial pathogens in an intensive-care unit. Infection Control and Hospital Epidemiology 18, 84–92.
71.Smith, DL et al. (2003) Assessing risks for a pre-emergent pathogen: virginiamycin use and the emergence of streptogramin resistance in Enterococcus faecium. Lancet Infectious Diseases 3, 241–249.
72.Suthar, N et al. (2014) An individual-based model of transmission of resistant bacteria in a veterinary teaching hospital. PLoS ONE 9, e98589.
73.Talaminos, A et al. (2016) Modelling the epidemiology of Escherichia coli ST131 and the impact of interventions on the community and healthcare centres. Epidemiology and Infection 144, 1974–1982.
74.Webb, GF et al. (2005) A model of antibiotic-resistant bacterial epidemics in hospitals. Proceedings of the National Academy of Sciences of the United States of America 102, 13343–13348.
75.Yahdi, M et al. (2012) Vancomycin-resistant enterococci colonization-infection model: parameter impacts and outbreak risks. Journal of Biological Dynamics 6, 645–662.
76.zur Wiesch, PA et al. (2014) Cycling empirical antibiotic therapy in hospitals: meta-analysis and models. PLoS Pathogens 10, e1004225.
77.Austin, DJ, Kakehashi, M and Anderson, RM (1997) The transmission dynamics of antibiotic-resistant bacteria: the relationship between resistance in commensal organisms and antibiotic consumption. Proceedings of the Royal Society B: Biological Sciences 264, 1629–1638.
78.Austin, DJ, Kristinsson, KG and Anderson, RM (1999) The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. Proceedings of the National Academy of Sciences of the United States of America 96, 1152–1156.
79.Chan, CH, McCabe, CJ and Fisman, DN (2012) Core groups, antimicrobial resistance and rebound in gonorrhoea in North America. Sexually Transmitted Infections 88, 200–204.
80.Colijn, C et al. (2010) What is the mechanism for persistent coexistence of drug-susceptible and drug-resistant strains of Streptococcus pneumoniae? Journal of the Royal Society Interface 7, 905–919.
81.Colijn, C and Cohen, T (2015) How competition governs whether moderate or aggressive treatment minimizes antibiotic resistance. eLife 4, e10559.
82.Domenech de Celles, M et al. (2011) Intrinsic epidemicity of Streptococcus pneumoniae depends on strain serotype and antibiotic susceptibility pattern. Antimicrobial Agents and Chemotherapy 55, 5255–5261.
83.Fingerhuth, SM et al. (2016) Antibiotic-resistant Neisseria gonorrhoeae spread faster with more treatment, not more sexual partners. PLoS Pathogens 12, e1005611.
84.Gao, D, Lietman, TM and Porco, TC (2015) Antibiotic resistance as collateral damage: the tragedy of the commons in a two-disease setting. Mathematical Biosciences 263, 121–132.
85.Gao, X, Pan, Q and He, M (2015) Transmission dynamics of resistant bacteria in a predator-prey system. Computational and Mathematical Models in Medicine 2015, 638074.
86.Handel, A, Regoes, RR and Antia, R (2006) The role of compensatory mutations in the emergence of drug resistance. PLoS Computational Biology 2, e137.
87.Hui, BB et al. (2015) Exploring the benefits of molecular testing for gonorrhoea antibiotic resistance surveillance in remote settings. PLoS ONE 10, e0133202.
88.Jansen, JP, Kumar, R and Carmeli, Y (2009) Accounting for the development of antibacterial resistance in the cost effectiveness of ertapenem versus piperacillin/tazobactam in the treatment of diabetic foot infections in the UK. Pharmacoeconomics 27, 1045–1056.
89.Levin, BR, Baquero, F and Johnsen, PJ (2014) A model-guided analysis and perspective on the evolution and epidemiology of antibiotic resistance and its future. Current Opinion in Microbiology 19, 83–89.
90.McCormick, AW et al. (2003) Geographic diversity and temporal trends of antimicrobial resistance in Streptococcus pneumoniae in the United States. Nature Medicine 9, 424–430.
91.Mitchell, PK, Lipsitch, M and Hanage, WP (2015) Carriage burden, multiple colonization and antibiotic pressure promote emergence of resistant vaccine escape pneumococci. Philosophical Transactions of the Royal Society of London Series B, Biological Sciences 370, 20140342.
92.Nielsen, KL et al. (2012) Fitness cost: a bacteriological explanation for the demise of the first international methicillin-resistant Staphylococcus aureus epidemic. Journal of Antimicrobial Chemotherapy 67, 1325–1332.
93.Opatowski, L et al. (2008) Antibiotic innovation may contribute to slowing the dissemination of multiresistant Streptococcus pneumoniae: the example of ketolides. PLoS ONE 3, e2089.
94.Opatowski, L et al. (2010) Antibiotic dose impact on resistance selection in the community: a mathematical model of beta-lactams and Streptococcus pneumoniae dynamics. Antimicrobial Agents and Chemotherapy 54, 2330–2337.
95.Porco, TC et al. (2012) When does overuse of antibiotics become a tragedy of the commons? PLoS ONE 7, e46505.
96.Samore, MH et al. (2006) Mechanisms by which antibiotics promote dissemination of resistant pneumococci in human populations. American Journal of Epidemiology 163, 160–170.
97.Smith, DL et al. (2002) Animal antibiotic use has an early but important impact on the emergence of antibiotic resistance in human commensal bacteria. Proceedings of the National Academy of Sciences of the United States of America 99, 6434–6439.
98.Temime, L et al. (2003) Bacterial resistance to penicillin G by decreased affinity of penicillin-binding proteins: a mathematical model. Emerging Infectious Diseases 9, 411–417.
99.Temime, L, Guillemot, D and Boëlle, PY (2004) Short- and long-term effects of pneumococcal conjugate vaccination of children on penicillin resistance. Antimicrobial Agents and Chemotherapy 48, 2206–2213.
100.Temime, L, Boëlle, P and Thomas, G (2005) Deterministic and stochastic modeling of pneumococcal resistance to penicillin. Mathematical Population Studies 12, 1–16.
101.Temime, L et al. (2005) Penicillin-resistant pneumococcal meningitis: high antibiotic exposure impedes new vaccine protection. Epidemiology and Infection 133, 493–501.
102.Trecker, MA et al. (2015) Revised simulation model does not predict rebound in gonorrhoea prevalence where core groups are treated in the presence of antimicrobial resistance. Sexually Transmitted Infections 91, 300–302.
103.Van Effelterre, T et al. (2010) A dynamic model of pneumococcal infection in the United States: implications for prevention through vaccination. Vaccine 28, 3650–3660.
104.Wang, YC and Lipsitch, M (2006) Upgrading antibiotic use within a class: tradeoff between resistance and treatment success. Proceedings of the National Academy of Sciences of the United States of America 103, 9655–9660.
105.Xiridou, M et al. (2015) Public health measures to control the spread of antimicrobial resistance in Neisseria gonorrhoeae in men who have sex with men. Epidemiology and Infection 143, 1575–1584.
106.Beams, AB et al. (2016) Harnessing intra-host strain competition to limit antibiotic resistance: mathematical model results. Bulletin of Mathematical Biology 78, 1828–1846.
107.Bonhoeffer, S, Lipsitch, M and Levin, BR (1997) Evaluating treatment protocols to prevent antibiotic resistance. Proceedings of the National Academy of Sciences of the United States of America 94, 12106–12111.
108.Boni, MF and Feldman, MW (2005) Evolution of antibiotic resistance by human and bacterial niche construction. Evolution 59, 477–491.
109.Gomes, ALC, Galagan, JE and Segrè, D (2013) Resource competition may lead to effective treatment of antibiotic resistant infections. PLoS ONE 8, e80775.
110.Levin, BR et al. (1997) The population genetics of antibiotic resistance. Clinical Infectious Diseases 24(Suppl. 1), S9–S16.
111.Saddler, CA et al. (2013) Epidemiological control of drug resistance and compensatory mutation under resistance testing and second-line therapy. Epidemics 5, 164–173.
112.Stewart, FM et al. (1998) The population genetics of antibiotic resistance II: analytic theory for sustained populations of bacteria in a community of hosts. Theoretical Population Biology 53, 152–165.
113.Sun, H, Lu, X and Ruan, S (2010) Qualitative analysis of models with different treatment protocols to prevent antibiotic resistance. Mathematical Biosciences 227, 56–67.
114.Osgood, N (2008) Using traditional and agent based toolsets for system dynamics: present tradeoffs and future evolution. In Sterman, J (ed.) Proceedings of the International Conference of the System Dynamics Society, pp. 21. Boston: Curran Associates, Inc.
115.Van Boeckel, TP et al. (2015) Global trends in antimicrobial use in food animals. Proceedings of the National Academy of Sciences of the United States of America 112, 5649–5654.
116.Volkova, VV et al. (2012) Mathematical model of plasmid-mediated resistance to ceftiofur in commensal enteric Escherichia coli of cattle. PLoS ONE 7, e36738.
117.Volkova, VV et al. (2013) Modelling dynamics of plasmid-gene mediated antimicrobial resistance in enteric bacteria using stochastic differential equations. Scientific Reports 3, 2463.
118.Lanzas, C et al. (2010) Transmission dynamics of a multidrug-resistant Salmonella typhimurium outbreak in a dairy farm. Foodborne Pathogens and Disease 7, 467–474.
119.Volkova, VV et al. (2013) Evaluating targets for control of plasmid-mediated antimicrobial resistance in enteric commensals of beef cattle: a modelling approach. Epidemiology and Infection 141, 2294–2312.
120.Garner, MJ et al. (2015) An assessment of antimicrobial resistant disease threats in Canada. PLoS ONE 10, e0125155.
121.Centers for Disease Control and Prevention (2013) Antibiotic Disease Threats in the United States, 2013. Atlanta, GA, USA: Centers for Disease Control.
122.Fishman, N (2006) Antimicrobial stewardship. American Journal of Infection Control 34(Suppl.), S55-S63.
123.Pelupessy, I, Bonten, MJM and Diekmann, O (2002) How to assess the relative importance of different colonization routes of pathogens within hospital settings. Proceedings of the National Academy of Sciences of the United States of America 99, 5601–5605.
124.Bootsma, MCJ et al. (2007) An algorithm to estimate the importance of bacterial acquisition routes in hospital settings. American Journal of Epidemiology 166, 841–851.
125.Raboud, J et al. (2005) Modeling the transmission of methicillin-resistant Staphylococcus aureus among patients admitted to a hospital. Infection Control and Hospital Epidemiology 26, 607–615.
126.Barnes, SL et al. (2014) Preventing the transmission of multidrug-resistant organisms: modelling the relative importance of hand hygiene and environmental cleaning interventions. Infection Control and Hospital Epidemiology 35, 1156–1162.
127.Levin, BR and Rozen, DE (2006) Non-inherited antibiotic resistance. Nature Reviews Microbiology 4, 556–562.
128.Bootsma, MCJ et al. (2012) Modeling non-inherited antibiotic resistance. Bulletin of Mathematical Biology 74, 1691–1705.
129.Lanzas, C et al. (2010) Model or meal? Farm animal populations as models for infectious diseases of humans. Nature Reviews Microbiology 8, 139–148.